title: Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals.
abstract: Cystic fibrosis (CF) mutation analysis on 437 CF patients, characterized 80 different mutations (20 so far specific to our population) accounting for 91% of CF genes and generating 103 different genotypes. Eight mutations were common [F508del (53.4%), 621+1G>T (5.7%), G542X (3.9%), N1303K (2.6%), 2789+5G>A (1.7%), 2183AA>G (1.4%), E822X (1.4%), R1158X (1%)], 12 showed frequencies between 0.5% and 1%, while the remaining (60) were very rare (1 to 3 alleles). Denaturing gradient gel electrophoresis (DGGE) screening of 12 exons (3, 4, 7, 10, 11, 13, 14b, 16, 17b 20 and 21) detected 85.5% of CF alleles. Haplotypes for eight diallelic and three microsatellite markers have been characterized for the common, a few rare and novel Greek mutations. Results of 165 prenatal diagnoses (including 49 due to bowel hyperechogenicity), testing a total of 41 different parental genotypes, are reported. One hundred and sixteen prenatal tests resulted in 22 affected, 59 heterozygous, 34 normal fetuses and one incomplete diagnosis. Of the 49 echogenic bowel fetuses, 3 were heterozygotes. Carrier screening was initiated, with emphasis on individuals and couples in high-risk groups - with a family history of CF, one partner with CF, and couples with male infertility seeking in vitro fertilization (IVF). Mutation analysis on 672 individuals (120 couples, 91 unaffected CF siblings, 283 CF family relatives and 58 general population subjects), identified a total of 176 heterozygotes and 7 couples where both partners were CF heterozygotes. Prenatal diagnosis was performed in 4 cases and 3 were counseled on the availability of a prenatal test.
authors.affiliation: Medical Genetics, Athens University; Cystic Fibrosis Unit, 'Aghia Sophia' Children's Hospital, Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Kanavakis
authors.forename: A
authors.initials: A
authors.lastname: Efthymiadou
authors.forename: S
authors.initials: S
authors.lastname: Strofalis
authors.forename: S
authors.initials: S
authors.lastname: Doudounakis
authors.forename: J
authors.initials: J
authors.lastname: Traeger-Synodinos
authors.forename: M
authors.initials: M
authors.lastname: Tzetis
mesh_terms: D000483:Alleles; D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000235:genetics*; D004252:DNA Mutational Analysis; D005091:Exons; D005260:Female; D005838:Genotype; D006115:Greece; D006239:Haplotypes; D006579:Heterozygote; D006801:Humans; D007438:Introns; D008297:Male; D018895:Microsatellite Repeats; D009154:Mutation; D011296:Prenatal Diagnosis; D012306:Risk